TechCrunch

Final days to apply for TC Top Picks at Disrupt SF 2019

Hey startup founders — don’t miss your opportunity to receive the VIP treatment and showcase your early-stage startup at Disrupt San Francisco 2019. Apply to be a TC Top Pick and exhibit in Startup ...
Nasdaq

TC BioPharm Announces Submission of Investigational New Drug (IND) Application to U.S. FDA for Treatment of Relapse/Refractory AML

Filing is supported by strong clinical data and IND enabling pre-clinical data associated withTCB-008 in treatment of Acute Myeloid Leukemia The IND application leverages pioneering research on the ...
Nasdaq

TC BioPharm's IND Application For TCB-008 In Acute Myeloid Leukemia Gets FDA Clearance

(RTTNews) - TC BioPharm (Holdings) Plc. (TCBP) Monday announced that the FDA provided clearance on an investigational new drug application for a Phase 1B study in relapse/refractory Acute Myeloid ...
TechCrunch

Mobility startups: apply for a free Startup Alley spot as a TC Top Pick

We’re hunting for bold, boundary-breaking founders of early-stage mobility startups to apply to our TC Top Picks program at Disrupt San Francisco 2019. “Bold and boundary-breaking” pretty much ...